Literature DB >> 28587050

Application of Critical Volume-Dose Constraints for Stereotactic Body Radiation Therapy in NRG Radiation Therapy Trials.

Timothy A Ritter1, Martha Matuszak2, Indrin J Chetty3, Charles S Mayo2, Jackie Wu4, Puneeth Iyengar5, Michael Weldon6, Clifford Robinson7, Ying Xiao8, Robert D Timmerman5.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28587050      PMCID： PMC5754194          DOI： 10.1016/j.ijrobp.2017.01.204

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  4 in total

1.  Stereotactic body radiation therapy: the report of AAPM Task Group 101.

Authors:  Stanley H Benedict; Kamil M Yenice; David Followill; James M Galvin; William Hinson; Brian Kavanagh; Paul Keall; Michael Lovelock; Sanford Meeks; Lech Papiez; Thomas Purdie; Ramaswamy Sadagopan; Michael C Schell; Bill Salter; David J Schlesinger; Almon S Shiu; Timothy Solberg; Danny Y Song; Volker Stieber; Robert Timmerman; Wolfgang A Tomé; Dirk Verellen; Lu Wang; Fang-Fang Yin
Journal:  Med Phys       Date:  2010-08       Impact factor: 4.071

Review 2.  Establishment of practice standards in nomenclature and prescription to enable construction of software and databases for knowledge-based practice review.

Authors:  Charles S Mayo; Thomas M Pisansky; Ivy A Petersen; Elizabeth S Yan; Brian J Davis; Scott L Stafford; Yolanda I Garces; Robert C Miller; James A Martenson; Robert W Mutter; Richard Choo; Christopher L Hallemeier; Nadia N Laack; Sean S Park; Daniel J Ma; Kenneth R Olivier; Sameer R Keole; Mirek Fatyga; Robert L Foote; Michael G Haddock
Journal:  Pract Radiat Oncol       Date:  2016-01-26

3.  A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases.

Authors:  Tracey E Schefter; Brian D Kavanagh; Robert D Timmerman; Higinia R Cardenes; Anna Baron; Laurie E Gaspar
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-08-01       Impact factor: 7.038

4.  Stereotactic body radiotherapy for primary hepatic malignancies - Report of a phase I/II institutional study.

Authors:  Ashley A Weiner; Jeffrey Olsen; Daniel Ma; Pawel Dyk; Todd DeWees; Robert J Myerson; Parag Parikh
Journal:  Radiother Oncol       Date:  2016-08-23       Impact factor: 6.280
  4 in total
  8 in total

Review 1.  Organs at Risk Considerations for Thoracic Stereotactic Body Radiation Therapy: What Is Safe for Lung Parenchyma?

Authors:  Feng-Ming Spring Kong; Vitali Moiseenko; Jing Zhao; Michael T Milano; Ling Li; Andreas Rimner; Shiva Das; X Allen Li; Moyed Miften; ZhongXing Liao; Mary Martel; Soren M Bentzen; Andrew Jackson; Jimm Grimm; Lawrence B Marks; Ellen Yorke
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-11-26       Impact factor: 8.013

2.  Development and Validation of a Comprehensive Multivariate Dosimetric Model for Predicting Late Genitourinary Toxicity Following Prostate Cancer Stereotactic Body Radiotherapy.

Authors:  Luca F Valle; Dan Ruan; Audrey Dang; Rebecca G Levin-Epstein; Ankur P Patel; Joanne B Weidhaas; Nicholas G Nickols; Percy P Lee; Daniel A Low; X Sharon Qi; Christopher R King; Michael L Steinberg; Patrick A Kupelian; Minsong Cao; Amar U Kishan
Journal:  Front Oncol       Date:  2020-05-20       Impact factor: 6.244

3.  Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial.

Authors:  David A Palma; Robert Olson; Stephen Harrow; Rohann J M Correa; Famke Schneiders; Cornelis J A Haasbeek; George B Rodrigues; Michael Lock; Brian P Yaremko; Glenn S Bauman; Belal Ahmad; Devin Schellenberg; Mitchell Liu; Stewart Gaede; Joanna Laba; Liam Mulroy; Sashendra Senthi; Alexander V Louie; Anand Swaminath; Anthony Chalmers; Andrew Warner; Ben J Slotman; Tanja D de Gruijl; Alison Allan; Suresh Senan
Journal:  BMC Cancer       Date:  2019-08-19       Impact factor: 4.430

4.  An International Expert Survey on the Indications and Practice of Radical Thoracic Reirradiation for Non-Small Cell Lung Cancer.

Authors:  Robert Rulach; David Ball; Kevin L M Chua; Max Dahele; Dirk De Ruysscher; Kevin Franks; Daniel Gomez; Matthias Guckenberger; Gerard G Hanna; Alexander V Louie; Drew Moghanaki; David A Palma; Clive Peedell; Ahmed Salem; Shankar Siva; Gregory M M Videtic; Anthony J Chalmers; Stephen Harrow
Journal:  Adv Radiat Oncol       Date:  2021-01-20

5.  Ablative radiation therapy to restrain everything safely treatable (ARREST): study protocol for a phase I trial treating polymetastatic cancer with stereotactic radiotherapy.

Authors:  Glenn S Bauman; Mark T Corkum; Hatim Fakir; Timothy K Nguyen; David A Palma
Journal:  BMC Cancer       Date:  2021-04-14       Impact factor: 4.430

6.  Lung Function After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer, Changes and Predictive Markers.

Authors:  Janna Berg; Christina Ramberg; Jon Olav Sulheim Haugstvedt; May-Bente Bengtson; Anne-Marie Gabrielsen; Odd Terje Brustugun; Ann Rita Halvorsen; Åslaug Helland
Journal:  Front Oncol       Date:  2021-05-24       Impact factor: 6.244

Review 7.  Radiation-induced lung injury - what do we know in the era of modern radiotherapy?

Authors:  Marek Konkol; Paweł Śniatała; Piotr Milecki
Journal:  Rep Pract Oncol Radiother       Date:  2022-07-29

Review 8.  Radiation-induced lung toxicity - cellular and molecular mechanisms of pathogenesis, management, and literature review.

Authors:  Lukas Käsmann; Alexander Dietrich; Claudia A Staab-Weijnitz; Farkhad Manapov; Jürgen Behr; Andreas Rimner; Branislav Jeremic; Suresh Senan; Dirk De Ruysscher; Kirsten Lauber; Claus Belka
Journal:  Radiat Oncol       Date:  2020-09-10       Impact factor: 3.481
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.